PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+20.77%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$707M
AUM Growth
+$707M
(+30%)
Cap. Flow
+$87.9M
Cap. Flow
% of AUM
12.44%
Top 10 Holdings %
Top 10 Hldgs %
36.4%
Holding
113
New
10
Increased
54
Reduced
24
Closed
24
Top Buys
| 1 |
Abbott
ABT
|
$17.3M |
| 2 |
Inspire Medical Systems
INSP
|
$15.6M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$13.3M |
| 4 |
Amgen
AMGN
|
$12M |
| 5 |
Syndax Pharmaceuticals
SNDX
|
$11.4M |
Top Sells
| 1 |
HCA Healthcare
HCA
|
$13.8M |
| 2 |
IMGN
Immunogen Inc
IMGN
|
$11.4M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$8.68M |
| 4 |
Charles River Laboratories
CRL
|
$8.65M |
| 5 |
Zimmer Biomet
ZBH
|
$7.97M |
Sector Composition
| 1 | Healthcare | 99.16% |
| 2 | Industrials | 0.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Nuvalent
NUVL
$5.74B
| $4.41M | 0.62% |
+59,867
| New | +$4.41M |
|
52
Merus
MRUS
$5.04B
| $4.34M | 0.61% |
157,817
+27,082
| +21% | +$745K |
|
53
Crinetics Pharmaceuticals
CRNX
$3.26B
| $4.29M | 0.6% |
120,652
+20,652
| +21% | +$735K |
|
54
Esperion Therapeutics
ESPR
$490M
| $4.26M | 0.6% |
1,425,204
-571,867
| -29% | -$1.71M |
|
55
BridgeBio Pharma
BBIO
$9.91B
| $4.07M | 0.57% |
100,734
+734
| +0.7% | +$29.6K |
|
|
SLN
56
Silence Therapeutics
SLN
$237M
| $4.05M | 0.57% |
232,942
+40,063
| +21% | +$696K |
|
57
Quanterix
QTRX
$202M
| $4M | 0.56% |
146,366
+69,279
| +90% | +$1.89M |
|
58
Lyra Therapeutics
LYRA
$11.8M
| $3.96M | 0.56% |
15,098
+2,597
| +21% | +$680K |
|
59
NeoGenomics
NEO
$1.06B
| $3.85M | 0.54% |
237,762
-8,050
| -3% | -$130K |
|
60
Dynavax Technologies
DVAX
$1.19B
| $3.55M | 0.5% |
+253,947
| New | +$3.55M |
|
61
TG Therapeutics
TGTX
$5.03B
| $3.51M | 0.49% |
205,317
-4,002
| -2% | -$68.4K |
|
62
Supernus Pharmaceuticals
SUPN
$2.52B
| $3.46M | 0.49% |
119,417
-18,755
| -14% | -$543K |
|
63
Applied Therapeutics
APLT
$73.7M
| $3.41M | 0.48% |
1,019,156
-730,844
| -42% | -$2.45M |
|
64
NewAmsterdam Pharma
NAMS
$2.8B
| $3.36M | 0.47% |
300,750
+51,726
| +21% | +$578K |
|
|
AKYA
65
DELISTED
Akoya BioSciences
AKYA
| $3.29M | 0.46% |
674,787
+149,164
| +28% | +$728K |
|
66
SI-BONE Inc
SIBN
$700M
| $3.06M | 0.43% |
145,575
-9,471
| -6% | -$199K |
|
67
UroGen Pharma
URGN
$896M
| $2.63M | 0.37% |
175,500
+30,189
| +21% | +$453K |
|
|
LBPH
68
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $2.59M | 0.37% |
429,892
+73,935
| +21% | +$446K |
|
69
89bio
ETNB
$1.37B
| $2.45M | 0.35% |
219,448
-144,105
| -40% | -$1.61M |
|
70
Acumen Pharmaceuticals
ABOS
$82.4M
| $2.32M | 0.33% |
603,497
+103,683
| +21% | +$398K |
|
|
SLGC
71
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $2.25M | 0.32% |
+890,099
| New | +$2.25M |
|
72
VYNE Therapeutics
VYNE
$8.09M
| $1.62M | 0.23% |
+696,470
| New | +$1.62M |
|
73
Structure Therapeutics
GPCR
$1.14B
| $1.58M | 0.22% |
38,678
+8,678
| +29% | +$354K |
|
74
Ironwood Pharmaceuticals
IRWD
$201M
| $1.38M | 0.19% |
120,652
+20,652
| +21% | +$236K |
|
75
Standard BioTools
LAB
$493M
| $1.33M | 0.19% |
603,620
+103,620
| +21% | +$229K |
|